Showing results (571-580 of 1,983) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|December 6, 2011
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational dataSarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, et al.The Lancet. Neurology|November 11, 2011
Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trialJusto Garcia de Yebenes, Bernhard Landwehrmeyer, Ferdinando Squitieri, et al.The Lancet. Neurology|October 22, 2011
Oral treatment for multiple sclerosisJoep Killestein, Richard A Rudick, Chris H PolmanThe Lancet. Neurology|February 24, 2009
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challengesDavid R Williams, Andrew J LeesThe Lancet. Neurology|June 23, 2009
Diagnosis, natural history, and management of Charcot-Marie-Tooth diseaseDavide Pareyson, Chiara MarchesiThe Lancet. Neurology|February 21, 2012
Cerebral microinfarcts: the invisible lesionsEric E Smith, Julie A Schneider, Joanna M Wardlaw, et al.The Lancet. Neurology|January 24, 2012
Clinically isolated syndromesDavid H Miller, Declan T Chard, Olga CiccarelliThe Lancet. Neurology|January 24, 2012
Cardiovascular and neurological causes of sudden death after ischaemic strokePeter Sörös, Vladimir HachinskiThe Lancet. Neurology|January 24, 2012
Non-coding RNAs with essential roles in neurodegenerative disordersEvgenia Salta, Bart De StrooperThe Lancet. Neurology|January 13, 2012
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyPeter Connick, Madhan Kolappan, Charles Crawley, et al.Pageof 199